Blázquez Ortiz, CristinaRuiz Calvo, AndreaBajo Grañeras, RaquelBaufreton, Jérôme M.Resel, EvaVarilh, MarjoriePagano Zottola, Antonio C.Mariani, YamunaCannich, AstridRodríguez Navarro, José A.Marsicano, GiovanniGalve Roperh, IsmaelBellocchio, LuigiGuzmán Pastor, Manuel2023-06-172023-06-172020-10-201554-863510.1080/15548627.2020.1827560https://hdl.handle.net/20.500.14352/8017The recreational and medical use of cannabis is largely increasing worldwide. Cannabis use, however, can cause adverse side effects, so conducting innovative studies aimed to understand and potentially reduce cannabis-evoked harms is important. Previous research conducted on cultured neural cells had supported that CNR1/CB1R (cannabinoid receptor 1), the main molecular target of cannabis, affects macroautophagy/autophagy. However, it was not known whether CNR1 controls autophagy in the brain in vivo, and, eventually, what the functional consequences of a potential CNR1-autophagy connection could be. We have now found that Δ9-tetrahydrocannabinol (THC), the major intoxicating constituent of cannabis, impairs autophagy in the mouse striatum. Administration of autophagy activators (specifically, the rapalog temsirolimus and the disaccharide trehalose) rescues THC-induced autophagy inhibition and motor dyscoordination. The combination of various genetic strategies in vivo supports the idea that CNR1 molecules located on neurons belonging to the direct (striatonigral) pathway are required for the autophagy- and motor-impairing activity of THC. By identifying autophagy as a mechanistic link between THC and motor performance, our findings may open a new conceptual view on how cannabis acts in the brain.engAtribución-NoComercial 3.0 Españajournal articlehttps://doi.org/10.1080/15548627.2020.1827560open access611.81633.888AutophagyCannabinoidDrug abuseMotor behaviorMTORStriatumMedicinas alternativasNeurociencias (Medicina)5101.13 Medicina Tradicional2490 Neurociencias